Risk Stratification and MRD-driven Maintenance for MM After ASCT
Risk Stratification and MRD-driven Maintenance for MM After ASCT
Recruiting · NCT06697483 · Registry updated 2024-11-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Risk Stratification and MRD-driven Maintenance for MM After ASCT | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not applicable | 2024-11-25 | NCT06697483 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuxing Hospital | Beijing | China | 1 |
| Peking Union Medical College Hospital | Beijing | China | 1 |
| Peking University People's Hospital | Beijing | China | 146 |
| The First Affiliated Hospital of Harbin Medical University | Harbin | China | 23 |